Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
about
Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trialStatins for multiple sclerosisStatins for multiple sclerosisImportance of Apolipoprotein A-I in Multiple SclerosisResidual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR TrialChronic mild stress eliminates the neuroprotective effect of Copaxone after CNS injury.Statin treatment in multiple sclerosis: a systematic review and meta-analysis.Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases.Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase.Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosisRandomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS studyInterference with RhoA-ROCK signaling mechanism in autoreactive CD4+ T cells enhances the bioavailability of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis.Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trialCombinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins.Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review.Arterial, venous and other vascular risk factors in multiple sclerosis.HDL in innate and adaptive immunity.Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.Multiple sclerosis: combination therapy in MS--still a valid strategy.Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).
P2860
Q21559486-3C1871A8-8304-4FA1-88FD-F3D0987A0484Q24234119-17F2922F-57C5-4F3A-B584-94D9A2AB3330Q24235592-D74DCE89-0DEF-4DCC-8D39-16DE45103EA2Q26774792-C50B45D1-9FDB-47A7-9A5B-9DB823BA1B3BQ28742007-8C11A718-6E86-4684-A312-C6D0828643D3Q30412083-26E35DDD-6FF8-4E30-B7E6-367FEA046472Q30913423-91AB399F-76D3-4075-8FDF-5F171D377D18Q33634866-8AF034DF-0204-49EF-B36A-F81EF973139BQ35111806-84688B82-791E-4647-98D0-B84251F22B42Q35205220-75A7D4C4-73CF-4A76-87E8-4A683D4AB67AQ35586845-6122A673-D04E-4A7F-9EA5-7E41DF2943DAQ35872344-37DEC551-08EA-4251-B1A3-78FBB1D15B3AQ36204144-B541BDE1-5110-4272-A5BD-040FD399391DQ36357176-EDFCDE1D-E8B9-4EB8-A235-E8691B194EADQ37373698-C5EF0D22-6F5D-4378-A636-C22E810313B1Q37543452-A5D64224-EAE3-46C8-B601-4E63A604BFEFQ38020536-65876223-CD57-4A65-95D3-6985F2060F53Q38042766-F3FCEBBF-03C9-41A2-B67F-262BEBDC51DAQ38220759-A707BF72-A9D8-4355-B80F-A14FB53AF326Q43164753-87D03883-49D5-472A-BE62-48D8E82361AFQ43704412-80DB1339-96BF-4037-A4D7-C422DD283DFCQ51062974-D4F27E1E-1E6D-46C2-9C04-B087B29A255DQ52147931-301E87A7-3ECB-4450-99BA-61F9D2C7C0F8
P2860
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effect of statins on clinical ...... ramuscular interferon beta-1a.
@ast
Effect of statins on clinical ...... ramuscular interferon beta-1a.
@en
type
label
Effect of statins on clinical ...... ramuscular interferon beta-1a.
@ast
Effect of statins on clinical ...... ramuscular interferon beta-1a.
@en
prefLabel
Effect of statins on clinical ...... ramuscular interferon beta-1a.
@ast
Effect of statins on clinical ...... ramuscular interferon beta-1a.
@en
P2093
P2860
P1433
P1476
Effect of statins on clinical ...... ramuscular interferon beta-1a.
@en
P2093
C Confavreux
F D Lublin
M R S Rani
R A Rudick
R M Ransohoff
P2860
P304
P356
10.1212/WNL.0B013E3181A92B96
P407
P577
2009-06-01T00:00:00Z